Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)
Recruiting now
Conditions studied: Monkeypox, MPOX
In brief
The study is a prospective cohort that evaluates the clinical and immune-metabolic variables that may be linked to the risk and severity of the infection or even hospitalization or death in patients infected with the Mpox virus in Brazil. The expectation is to include at least 80 patients over six months, with a follow-up of 90 days from inclusion, through contact via decentralized visits.
Key facts
- Study ID
- NCT05784038
- Run by
- Hospital Israelita Albert Einstein
- People needed
- 80
- Starts
- 2024-07-16
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2024-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women aged ≥ 18 years with confirmed MPOX infection.
- (laboratory-confirmed monkeypox infection is defined as determined by PCR, culture, or antigen test obtained from a sample collected from blood, oropharynx, anal or skin lesion within 4 days of randomization)
You may not qualify if…
- Inability to provide informed consent;
- Patient who, judging by the study team, does not have a condition for decentralized follow-up
Where it is running
- Hospital Universitário João de Barros Barreto — Belém, Pará, Brazil (enrolling)
- Hospital Israelita Albert Einstein — São Paulo, São Paulo, Brazil (enrolling)
- Hospital Naval Marcílio Dias — Rio de Janeiro, Brazil (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.